Hydride Activation via the Trans Influence
Organometallics, Vol. 19, No. 18, 2000 3629
1
removed in vacuo and the resulting precipitate dissolved in
n-hexane at 0 °C, then filtered through a layer of Celite. After
removal of the solvent, drying under dynamic vacuum, and
recrystallization in CH2Cl2/hexane, 2.21 g of 5 (3.4 mmol, 85%)
was obtained as orange crystals.
of the hydride 7 (1.53 mmol, 96%). H NMR (C6D6, 298 K): δ
6.72 (s, 2H, Mes), 2.62 (s, 6H, 2CH3-Mes), 2.05 (s, 3H, CH3-
Mes), 1.67 (s br, 12H, PMe), 1.52 (m br, 4H, PCH2), 1.46 (s br,
12H, PMe′), 1.42 (m br, 4H, PCH2′), -6.58 (q, 1H, 2J HP ) 32.10
Hz, J HW ) 31.50 Hz, WH). 31P{1H} NMR (C6D6, 298 K): δ
1
24.4 (s, J PW ) 281 Hz). 13C{1H} NMR (C6D6, 298 K): δ 260.4
1
Alternative method: to a stirred solution of 5a (1.0 g, 1.59
mmol) in acetonitrile were added dmpe (0.60 mL, 3.5 mmol)
and a large excess of zinc. After 24 h at 25 °C, the organic
phase was decanted and reduced to dryness under vacuum.
The remaining solid was extracted with CH2Cl2 and the extract
filtered, concentrated, and recrystallized in CH2Cl2/hexane,
giving 5b (0.95 mmol, 60%). 1H NMR (toluene-d8, 298 K): δ
6.60 (s, 2H, Mes), 2.50 (s, 6H, 2CH3-Mes), 1.97 (s, 3H, CH3-
Mes), 1.55 (br, 4H, PCH2), 1.47 (s br, 12H, PMe), 1.43 (s br,
12H, PMe′), 1.18 (br, 4H, PCH2′). 31P{1H} NMR (toluene-d8,
2
(q, J CP ) 10 Hz, CMes), 151.5 (s, ipso-Mes), 137.4 (s, o-Mes),
135.4 (s, p-Mes), 130.8 (s, m-Mes), 34.0 (q, PCH2), 27.8 (m,
PMe), 25.4 (m, PMe′), 22.6 (s, 2CH3-Mes), 21.5 (s, CH3-Mes).
183W {1H} NMR (toluene-d8, 298 K: δ -1612 (pseudo-q, J WP
1
) 281 Hz). MS (FAB, toluene): m/e 615 (M+), 310 (M+
-
2dmpe). Anal. Calcd for WC22H44P4 (615.73): W, 29.86; C,
42.87; H, 7.15. Found: W, 29.26; C, 42.67; H, 7.28.
P r ep a r a tion of tr a n s-W(CMes)(d m p e)2(D) (7a ). Com-
pound 7a was prepared in analogous fashion to compound 7,
utilizing 0.1 g (0.16 mmol) of compound 6a , 0.05 g (0.45 mmol)
of quinuclidine, and 30 mL of THF. Recrystallization in CH2-
Cl2/pentane afforded 0.07 g of 7a (0.11 mmol, 70%) as red
crystals. 2D NMR (toluene-d8, 183 K): δ -6.60 (m br, WD).
P r ep a r a tion of tr a n s-W(CMes)(η1-OC(O)H)(d m p e)2 (8).
A red solution of the hydride 7 (50 mg, 0.08 mmol) in THF (15
mL) was stirred under 1 bar of carbon dioxide for 30 min at
-25 °C. The solution became immediately bright orange. The
resulting mixture was then allowed to warm to room temper-
ature, and the solvent and excess CO2 were rapidly removed
under high vacuum. The residue was washed three times with
pentane (3 × 10 mL) to afford after recrystallization in diethyl
ether 53.6 mg of the η1-formate complex 8 (0.068 mmol, 85%)
as orange crystals. 1H NMR (toluene-d8, 298 K): δ 8.25 (s, 1H,
OC(O)H), 6.56 (s, 2H, Mes), 2.50 (s, 6H, 2CH3-Mes), 1.96 (s,
3H, CH3-Mes), 1.60 (s br, 12H, PMe), 1.43 (m br, 4H, PCH2),
1.30 (s br, 12H, PMe′), 1.27 (m br, 4H, PCH2′). 31P{1H} NMR
1
298 K): δ 23.12 (s, J pw ) 282 Hz). 13C{1H} NMR (toluene-d8,
2
298 K): δ 260.4 (q, J cp ) 10 Hz, CMes), 147.9 (s, ipso-Mes),
136.1 (s, o-Mes), 132.2 (s, p-Mes), 128.0 (s, m-Mes), 33.7 (q,
PCH2), 23.1 (s, 2CH3-Mes), 22.4 (q, PMe), 21.3 (s, CH3-Mes),
18.2 (q, PMe′). IR (THF, cm-1): νWtC 928 (m). MS (FAB, CH2-
Cl2): m/e 650 (M+), 500 (M+ - dmpe), 390 (M+ - dmpe - Mes).
Anal. Calcd for WC22H43P4Cl (650.18): W, 28.27; C, 40.60; H,
6.61. Found: W, 28.20; C, 40.74; H, 6.33.
P r ep a r a tion of tr a n s-W(CMes)(η1-HBH3)(d m p e)2 (6).
Compound 5 (2.0 g, 3.08 mmol) was dissolved in THF (50 mL)
and NaBH4 (0.35 g, 9.23 mmol) added. The resulting mixture
was warmed to 55 °C and stirred at this temperature for 12
h; then the solvent was removed in vacuo, and the precipitate
redissolved in benzene. After filtration over Celite, the solvent
was again removed in vacuo, and the precipitate was washed
with pentane (3 × 20 mL) and recrystallized in CH2Cl2/pentane
to afford 1.9 g of 6 (3.02 mmol, 98%) as brown microcrystals.
1H NMR (THF-d8, 298 K): δ 6.70 (s, 2H, Mes), 2.52 (s, 6H,
2CH3-Mes), 1.99 (s, 3H, CH3-Mes), 1.77 (br, 4H, PCH2), 1.67
(s br, 12H, PMe), 1.38 (s br, 12H, PMe′), 1.20 (br, 4H, PCH2′),
-2.30 (d br, HBH3). 31P{1H} NMR (THF-d8, 298 K): δ 22.4 (s,
1J PW ) 281 Hz). 13C{1H} NMR (THF-d8, 298 K): δ 266.5 (q,
2J CP ) 9 Hz, CMes), 148.0 (s, ipso-Mes), 136.2 (s, o-Mes), 133.3
(s, p-Mes), 128.2 (s, m-Mes), 34.0 (q, PCH2), 23.4 (m, PMe),
22.8 (s, 2CH3-Mes), 21.3 (s, CH3-Mes), 20.7 (q, PMe′). IR (THF,
cm-1): νWtC 927 (m), νB-Ht 2352 (s), νB-Hb 2035 (s), νW-Hb 1740
(m br). MS (FAB, toluene): m/e 630 (M+), 615 (M+ - BH4), 310
(M+ - BH4 - 2dmpe). Anal. Calcd for WC22H47P4B (629.54):
C, 41.93; H, 7.47. Found: C, 42.30; H, 7.61.
P r ep a r a tion of tr a n s-W(CMes)(η1-DBD3)(d m p e)2 (6a ).
Compound 6a was prepared in an analogous fashion to
compound 6, utilizing 0.2 g (0.31 mmol) of compound 5, 0.03 g
(0.72 mmol) of NaBD4, and 50 mL of THF. Recrystallization
in CH2Cl2/pentane afforded 0.18 g of 6a (0.28 mmol, 90%) as
brown microcrystals. This compound closely resembles 6 in
its spectroscopic properties. 2D NMR (toluene-d8, 293 K):
δ-2.65 (s br, DBD3). 11B NMR (toluene-d8, 293 K): δ -2.3 (s
br, DBD3).
(toluene-d8, 298 K): δ 31.3 (s, J PW ) 286 Hz). 13C{1H} NMR
(toluene-d8, 298 K): δ 263.4 (q, J CP ) 9 Hz, CMes), 165.9 (s,
1
2
OC(O)H), 147.8 (s, ipso-Mes), 137.4 (s, o-Mes), 135.2 (s, p-Mes),
131.5 (s, m-Mes), 33.4 (m, PCH2), 30.1 (m, PMe), 25.0 (s, 2CH3-
Mes), 22.7 (m, PMe′), 21.1 (s, CH3-Mes). IR (THF, cm-1): νWt
921 (m); ν(OCO) 1962, 1621. MS (FAB, CH2Cl2): m/e 660 (M+),
C
615 (M+ - CO2H), 510 (M+ - dmpe). Anal. Calcd for
WC23H44P4O2 (659.73): C, 41.83; H, 6.67. Found: C, 41.83; H,
6.75.
P r epar ation of tr a n s-W(CMes)(η1-OP r )(dm pe)2 (9). Com-
pound 7 (30 mg, 0.0487 mmol) was dissolved in toluene (5 mL)
and propionaldehyde (3.54 µL, 0.0487 mmol) added by mi-
crosyringe at room temperature. The red solution became
immediately orange. After a few minutes, the solvent was
removed in vacuo and the precipitate recrystallized in CH2-
Cl2/pentane at -30 °C to afford 9. Yield: 27 mg (90%). 1H NMR
(toluene-d8, 298 K): δ 6.74 (s, 2H, Mes), 3.21 (t, 2H, O-CH2),
2.62 (s, 2CH3-Mes), 2.07 (s, CH3-Mes), 1.54 (s br, 12H, PMe),
1.48 (m br, 4H, PCH2), 1.37 (s br, 12H, PMe′), 1.33 (m br, 4H,
PCH2′). 31P{1H} NMR (toluene-d8, 298 K): δ 25.3 (s, J PW
)
)
1
288 Hz). 13C{1H} NMR (toluene-d8, 298 K): δ 247.6 (q, J CP
2
9 Hz, CMes), 149.2 (s, ipso-Mes), 136.0 (s, o-Mes), 130.4 (s,
p-Mes), 128.0 (s, m-Mes), 73.2 (s br, O-CH2), 33.5 (q, PCH2),
23.0 (s, 2CH3-Mes), 22.5 (m, PMe), 21.2 (s, CH3-Mes), 18.1 (m,
P r ep a r a tion of tr a n s-W(CMes)(d m p e)2(H) (7). Com-
pound 6 (1.0 g, 1.59 mmol) was dissolved in THF (30 mL), and
quinuclidine (0.53 g, 4.76 mmol) was added. The resulting
mixture was stirred 3 h at 30 °C and then 3 h at 45 °C. The
solvent was removed in vacuo, and the precipitate redissolved
in n-hexane. After filtration over Celite, the solvent and excess
quinuclidine were removed in vacuo for 4 h at 50 °C, to afford
after recrystallization in CH2Cl2/pentane 0.96 g of the hydride
7 (1.56 mmol, 98%) as red crystals.
An alternative method could be employed, using 1.0 g (1.59
mmol) of 6 in THF (30 mL) and 2.46 mL of PMe3 (23.85 mmol,
15 equiv), instead of quinuclidine. The resulting mixture was
stirred 3 days at room temperature. The solvent and the
byproduct Me3PBH3 were removed by sublimation under
dynamic vacuum at 50 °C for 2 h. The solid was dissolved in
benzene and filtered over Celite. Removal of the solvent from
the filtrate and then washing the solid with pentane (3 × 20
mL) afforded after recrystallization in CH2Cl2/pentane 0.94 g
PMe′). MS (EI): m/e 674 (M+), 616 (M+ - OPr), 523 (M+
-
dmpe). Anal. Calcd for WC25H50P4O (673.73): C, 44.53; H, 7.42.
Found: C, 44.48; H, 7.03.
P r ep a r a tion of tr a n s-W(CMes)(η1-OBn )(d m p e)2 (10).
Compound 7 (30 mg, 0.0487 mmol) was dissolved in toluene
(5 mL) and benzaldehyde (5.0 µL, 0.0487 mmol) added by
microsyringe at room temperature. An immediate color change
from red to orange was observed. After a few minutes, the
solvent was removed in vacuo and the precipitate recrystal-
lized in CH2Cl2/pentane at -30 °C to afford 10. Yield: 29 mg
1
(97%). H NMR (toluene-d8, 298 K): δ 7.39 (d, 2H, o-benzal.),
7.13 (d, 1H, p-benzal.), 6.96 (m, 2H, m-benzal.), 6.60 (s, 2H,
Mes), 4.23 (s, 2H, CH2O), 2.52 (s, 6H, 2CH3-Mes), 1.98 (s, 3H,
CH3-Mes), 1.46 (s br, 12H, PMe), 1.42 (m br, 4H, PCH2), 1.34
(s br, 12H, PMe′), 1.25 (m br, 4H, PCH2′). 31P{1H} NMR